Mastijet Forte
|
-
|
V/NRP/96/0344
|
Intervet International B.V., Nīderlande
|
QJ51RV01
|
lactating cows
|
Vairāk
|
Medicinal product information
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/NRP/96/0344-01 |
|
20 |
Injektors, 1 deva |
[PDF]
[PDF]
|
|
Mastijet Forte
|
-
|
V/I/21/0068
|
Intervet International BV, Nīderlande
|
QJ51RV01
|
lactating cows
|
|
Medicinal product information
Pharmaceutical form: |
intramammary suspension
|
International name (active substance): |
Tetracycline, Neomycin, Bacitracin, Prednisolone
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
Date of authorisation/renewal: |
09-Nov-2021
|
Marketing authorisation valid until: |
08-Nov-2026
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] Mastijet_Forte_PL_2023_06 (06-Jul-2023)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/21/0068-01 |
|
20 |
Polipropilēna šļirce, 8 g |
[PDF]
|
|
Mastijet Forte
|
-
|
V/I/21/0043
|
Intervet International BV, Nīderlande
|
QJ51RV01
|
lactating cows
|
Vairāk
|
Medicinal product information
Pharmaceutical form: |
intramammary suspension
|
International name (active substance): |
Neomycin, Tetracycline hydrochloridum, Bacitracin, Prednisolone
|
Distribution category: |
To be supplied only on veterinary prescription
|
Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
Date of authorisation/renewal: |
19-Jun-2021
|
Marketing authorisation valid until: |
18-Jun-2026
|
Marketing authorisation procedure: |
I
|
Package leaflet: |
[DOCX] 27072023_LI (27-Jul-2023)
|
Labelling text: |
See products section
|
Summary of product characteristics: |
-
|
Products
ID |
Strength |
Package size |
Primary packaging |
Labelling |
V/I/21/0043-01 |
|
20 |
Polipropilēna šļirce, 8 g |
[PDF]
[PDF]
|
|